Cite
Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillance.
MLA
Grigg, Matthew J., et al. “Plasmodium Falciparum Artemisinin Resistance Monitoring in Sabah, Malaysia: In Vivo Therapeutic Efficacy and Kelch13 Molecular Marker Surveillance.” Malaria Journal, vol. 17, no. 1, Dec. 2018, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s12936-018-2593-x.
APA
Grigg, M. J., William, T., Piera, K. A., Rajahram, G. S., Jelip, J., Aziz, A., Menon, J., Marfurt, J., Price, R. N., Auburn, S., Barber, B. E., Yeo, T. W., & Anstey, N. M. (2018). Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillance. Malaria Journal, 17(1), N.PAG. https://doi.org/10.1186/s12936-018-2593-x
Chicago
Grigg, Matthew J., Timothy William, Kim A. Piera, Giri S. Rajahram, Jenarun Jelip, Ammar Aziz, Jayaram Menon, et al. 2018. “Plasmodium Falciparum Artemisinin Resistance Monitoring in Sabah, Malaysia: In Vivo Therapeutic Efficacy and Kelch13 Molecular Marker Surveillance.” Malaria Journal 17 (1): N.PAG. doi:10.1186/s12936-018-2593-x.